Platform Overview
Features
Cardiac AmyloidosisHeart FailureAortic StenosisPulmonary HypertensionStrain
Operations
Operational ImpactIT & ProcurementReimbursementsCore Lab SolutionsEHR Mining
Clinical Evidence
Our StoryCareersMedia Kit
NewsContact Us Login Book a Demo

Latest News

Stay updated with the latest developments, partnerships, and breakthroughs from Us2.ai.

105 articles
What TARTAN-HF Reveals About Diabetes and Undiagnosed Heart Failure
Mar 30, 2026

What TARTAN-HF Reveals About Diabetes and Undiagnosed Heart Failure

The results from the TARTAN-HF (Targeted assessment in high-risk patients with diabetes to identify undiagnosed heart failure) trial, presented as a late-breaking featured science presentation at the ...

Early Detection of Atrial Myxoma With Echocardiography
Mar 25, 2026

Early Detection of Atrial Myxoma With Echocardiography

Us2.ai co-founder Dr. Carolyn Lam was quoted in Newsweek on a rare cardiac case that underscores a truth at the heart of what we do: the right imaging, at the right moment, changes everything.

Alnylam and Viz.ai Build ATTR-CM Early Detection Pathway with Us2.ai Echo AI
Mar 24, 2026

Alnylam and Viz.ai Build ATTR-CM Early Detection Pathway with Us2.ai Echo AI

Us2.ai has been selected as the echocardiography AI algorithm at the heart of Alnylam and Viz.ai's strategic collaboration, combining FDA-cleared echo AI with EHR connectivity to build an AI-enabled A...

What changing blood pressure guidelines signal for the future of personalised cardiovascular care
Mar 24, 2026

What changing blood pressure guidelines signal for the future of personalised cardiovascular care

Us2.ai co-founder Dr. Carolyn Lam was quoted in The Epoch Times on the 2025 AHA blood pressure guidelines and what the shift toward risk-guided treatment means for cardiovascular care. As clinical com...

Clinical Expertise Behind Us2.ai: Dr. Carolyn Lam on Women’s Heart Health
Jan 28, 2026

Clinical Expertise Behind Us2.ai: Dr. Carolyn Lam on Women’s Heart Health

Us2.ai Co-Founder Carolyn Lam Quoted in National Geographic on Exercise, Heart Health & Women’s Outcomes

Us2.ai obtains Type 1 C5 attestation
Dec 15, 2025

Us2.ai obtains Type 1 C5 attestation

Big news! Us2.ai has achieved the Type 1 C5 attestation!

Merge partners with Us2.ai to transform cardiology diagnostics with AI-generated echocardiogram measurements
Nov 13, 2025

Merge partners with Us2.ai to transform cardiology diagnostics with AI-generated echocardiogram measurements

The partnership integrates Us2.ai’s cutting-edge, FDA-cleared algorithms with Merge Cardio’s advanced imaging systems to deliver AI-generated analysis and reporting of echocardiograms.

AI-SCREEN-CA: Uncovering Hidden Cardiac Amyloidosis with AI-Driven Echocardiography
Nov 12, 2025

AI-SCREEN-CA: Uncovering Hidden Cardiac Amyloidosis with AI-Driven Echocardiography

Presented at the American Heart Association Scientific Sessions 2025 (AHA25) by researchers from Juntendo University (Tokyo, Japan), the AI-SCREEN-CA study evaluated the real-world performance of arti...

Us2.ai joins Harrision.ai’s Medical Imaging AI Open Platform
Nov 7, 2025

Us2.ai joins Harrision.ai’s Medical Imaging AI Open Platform

Us2.ai is proud to be one of the leading AI vendors partnering with Harrison.ai Radiology on their newly launched Open Platform — a bold step toward transforming access to medical imaging AI.